Virpax Pharmaceuticals Inc (VRPX)

$0.35 -0.32 (-47.72%)
Market Cap 1.52M
Revenue (ttm) 0.00
Net Income (ttm) -12.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 148,800
Avg Vol 489,540
Day's Range N/A - N/A
Shares Out 1.24M
Stochastic %K 13%
Beta 1.41
Analysts Hold
Price Target $3.00

Company Profile

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta,...

Industry: Biotechnology
Sector: Healthcare
Phone: 610 727 4597
Address:
1055 Westlakes Drive, Suite 300, Berwyn, United States
Bio_Be_Dirty
Bio_Be_Dirty Feb. 13 at 6:57 PM
$VRPX when 12
0 · Reply
Rasto2020
Rasto2020 Feb. 6 at 2:10 PM
$VRPX this was my biggest loss of last year. Would I have stayed and dwelled on it , I would have lost everything.
1 · Reply
TheAwfulTrader
TheAwfulTrader Jan. 28 at 12:51 PM
$VRPX I need this baby to rise from the dead. Invested around $30K and it’s now worth under $1
0 · Reply
TheAwfulTrader
TheAwfulTrader Jan. 9 at 3:02 PM
$VRPX she about to take off?
0 · Reply
RIVNMomentumMan
RIVNMomentumMan Jan. 7 at 2:54 PM
$VRPX
0 · Reply
miraclehunter
miraclehunter Jan. 5 at 6:40 AM
$VRPX .03
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 19 at 6:27 PM
$VRPX rise my pet I need U
0 · Reply
TootaLoo
TootaLoo Aug. 27 at 1:58 PM
$VRPX So this toast, right?
0 · Reply
YGS
YGS Jul. 26 at 5:38 PM
$VRPX I've been watching this stock for a while. Good chance that anyone holding a bag might have a chance to be a part of a future class action.
0 · Reply
Smallportfolio
Smallportfolio Jul. 22 at 7:16 PM
$VRPX I guess at this point ride to zero
2 · Reply
Latest News on VRPX
Virpax Pharmaceuticals Announces Reverse Stock Split

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Virpax Pharmaceuticals Announces Reverse Stock Split

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Mar 18, 2025, 4:01 PM EDT - 1 year ago

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Mar 7, 2025, 8:00 AM EST - 1 year ago

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Mar 5, 2025, 4:01 PM EST - 1 year ago

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Feb 27, 2025, 4:01 PM EST - 1 year ago

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

Feb 14, 2025, 12:46 PM EST - 1 year ago

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Feb 13, 2025, 4:01 PM EST - 1 year ago

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Jan 31, 2025, 8:30 AM EST - 1 year ago

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Jan 30, 2025, 3:59 PM EST - 1 year ago

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Jan 30, 2025, 9:23 AM EST - 1 year ago

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Jan 28, 2025, 9:15 AM EST - 1 year ago

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

Nov 22, 2024, 8:30 AM EST - 1 year ago

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

Nov 21, 2024, 4:05 PM EST - 1 year ago

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

Nov 18, 2024, 10:23 AM EST - 1 year ago

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Nov 15, 2024, 4:09 PM EST - 1 year ago

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Nov 13, 2024, 9:15 AM EST - 1 year ago

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

Oct 9, 2024, 12:21 PM EDT - 1 year ago

This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

FDS BX DQ

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Aug 13, 2024, 7:30 AM EDT - 1 year ago

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Aug 8, 2024, 7:30 AM EDT - 1 year ago

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Jul 24, 2024, 7:30 AM EDT - 1 year ago

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher

Jul 10, 2024, 12:12 PM EDT - 1 year ago

Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

Jul 10, 2024, 11:29 AM EDT - 1 year ago

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

What's Going With Penny Stock Virpax Pharmaceuticals On Monday?

Jul 8, 2024, 12:09 PM EDT - 1 year ago

What's Going With Penny Stock Virpax Pharmaceuticals On Monday?

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Jul 8, 2024, 7:30 AM EDT - 1 year ago

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

May 29, 2024, 7:30 AM EDT - 1 year ago

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

Virpax Announces Pricing of $2.25 Million Public Offering

May 15, 2024, 8:00 AM EDT - 1 year ago

Virpax Announces Pricing of $2.25 Million Public Offering

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

May 13, 2024, 4:10 PM EDT - 1 year ago

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

Apr 30, 2024, 7:30 AM EDT - 1 year ago

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

Virpax Pharmaceuticals Reports 2023 Year-End Results

Mar 26, 2024, 7:30 AM EDT - 2 years ago

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price

Feb 27, 2024, 7:31 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Feb 27, 2024, 7:30 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

Feb 7, 2024, 7:30 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

Dec 29, 2023, 7:30 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

Nov 17, 2023, 7:10 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

Virpax Pharmaceuticals Announces Leadership Transition

Nov 17, 2023, 7:00 AM EST - 2 years ago

Virpax Pharmaceuticals Announces Leadership Transition

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

Nov 15, 2023, 4:15 PM EST - 2 years ago

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review

Oct 31, 2023, 8:58 AM EDT - 2 years ago

Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review

Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research

Oct 12, 2023, 8:02 AM EDT - 2 years ago

Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research

Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies

Sep 27, 2023, 8:58 AM EDT - 2 years ago

Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies

Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI

Sep 26, 2023, 8:58 AM EDT - 2 years ago

Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses

Sep 21, 2023, 10:00 AM EDT - 2 years ago

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals

Sep 18, 2023, 7:58 AM EDT - 2 years ago

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals

Virpax Pharmaceuticals Updates on Litigation

Sep 5, 2023, 9:00 AM EDT - 2 years ago

Virpax Pharmaceuticals Updates on Litigation

SCLX

Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

Aug 28, 2023, 8:58 AM EDT - 2 years ago

Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

Aug 14, 2023, 9:00 AM EDT - 2 years ago

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method

Aug 10, 2023, 8:58 AM EDT - 2 years ago

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method

Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023

Jul 24, 2023, 7:00 AM EDT - 2 years ago

Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023

Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments

May 12, 2023, 4:08 PM EDT - 3 years ago

Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments

Nanomerics Announces Ocular Molecular Envelope Technology (MET) Patent Granted in Canada

Apr 13, 2023, 5:20 AM EDT - 3 years ago

Nanomerics Announces Ocular Molecular Envelope Technology (MET) Patent Granted in Canada

Virpax Reports on Progress of Envelta™

Apr 5, 2023, 8:58 AM EDT - 3 years ago

Virpax Reports on Progress of Envelta™

Bio_Be_Dirty
Bio_Be_Dirty Feb. 13 at 6:57 PM
$VRPX when 12
0 · Reply
Rasto2020
Rasto2020 Feb. 6 at 2:10 PM
$VRPX this was my biggest loss of last year. Would I have stayed and dwelled on it , I would have lost everything.
1 · Reply
TheAwfulTrader
TheAwfulTrader Jan. 28 at 12:51 PM
$VRPX I need this baby to rise from the dead. Invested around $30K and it’s now worth under $1
0 · Reply
TheAwfulTrader
TheAwfulTrader Jan. 9 at 3:02 PM
$VRPX she about to take off?
0 · Reply
RIVNMomentumMan
RIVNMomentumMan Jan. 7 at 2:54 PM
$VRPX
0 · Reply
miraclehunter
miraclehunter Jan. 5 at 6:40 AM
$VRPX .03
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 19 at 6:27 PM
$VRPX rise my pet I need U
0 · Reply
TootaLoo
TootaLoo Aug. 27 at 1:58 PM
$VRPX So this toast, right?
0 · Reply
YGS
YGS Jul. 26 at 5:38 PM
$VRPX I've been watching this stock for a while. Good chance that anyone holding a bag might have a chance to be a part of a future class action.
0 · Reply
Smallportfolio
Smallportfolio Jul. 22 at 7:16 PM
$VRPX I guess at this point ride to zero
2 · Reply
moneyinmotion007
moneyinmotion007 Jul. 22 at 5:40 PM
$VRPX i have no clue what's happening here
0 · Reply
Draganafly
Draganafly Jul. 17 at 2:25 PM
$VRPX Delisted is Done 😣
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 2 at 10:36 AM
$LIXT temp bringing u a lil down here 1.05/1.07 old $VRPX
0 · Reply
ttvenu
ttvenu Jun. 24 at 8:45 PM
$VRPX Probudur now has T-shirts now? What's actually going on?
0 · Reply
DTPantera
DTPantera Jun. 24 at 2:37 PM
$VRPX what's happening here?
1 · Reply
MangTok1234
MangTok1234 Jun. 17 at 3:19 PM
$VRPX bueler?
0 · Reply
Sweet7312
Sweet7312 Jun. 4 at 6:55 PM
$VRPX can back growth if they find a new control system on the new variant COVID that find on China and France To look a new vaccine on this COVID
0 · Reply